Skip to main content
SpringerLink
Log in

Thyroid Hormones

  • Chapter
Cutaneous Manifestations of Endocrine Diseases

  • 966 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol. 2003;48(5):641–59.

    Article  PubMed  Google Scholar 

  • Bongartz G. Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? MAGMA. 2007;20(2):57–62.

    Article  PubMed  CAS  Google Scholar 

  • Burman KD, McKinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol. 2006;24(4):247–55.

    Article  PubMed  Google Scholar 

  • Centers for Disease Control and Prevention (CDC). Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents—St. Louis, Missouri, 2002–2006. MMWR Morb Mortal Wkly Rep. 2007;56(7):137–41.

    Google Scholar 

  • Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001;23(5):383–93.

    Article  PubMed  CAS  Google Scholar 

  • Davies TF, Larsen R P. Thyrotoxicos, pp 374–422. In: Williams Textbook of Endocrinology, 10th Edition, Eds: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, Saunders, PA 2003.

    Google Scholar 

  • Edsall LC, English JC 3rd, Teague M W, Patterson J W. Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J Cutan Pathol 2004;31(3):247–53.

    Article  PubMed  Google Scholar 

  • Edward M, Fitzgerald L, Thind C, Leman J, Burden AD. Cutaneous mucinosis associated with dermatomyositis and nephrogenic fibrosing dermopathy: fibroblast hyaluronan synthesis and the effect of patient serum. Br J Dermatol. 2007;156(3):473–9.

    Article  PubMed  CAS  Google Scholar 

  • Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005;6(5):295–309.

    Article  PubMed  Google Scholar 

  • Georgakis CD, Falasca G, Georgakis A, Heymann WR. Scleromyxedema. Clin Dermatol. 2006;24(6):493–7.

    Article  PubMed  Google Scholar 

  • Grobner T, Prischl FC. Gadolinium and nephrogenic systemic fibrosis. Kidney Int. 2007;72(3):260–4.

    Article  PubMed  CAS  Google Scholar 

  • Harris JE, Purcell SM, Griffin TD. Acral persistent papular mucinosis. J Am Acad Dermatol. 2004;51(6):982–8.

    Article  PubMed  Google Scholar 

  • Haustein U F. Scleroderma and pseudo-scleroderma: uncommon presentations. Clin Dermatol. 2005;23(5):480–90.

    Article  PubMed  Google Scholar 

  • Hershko K, Hull C, Ettefagh L, Nedorost S, Dyson S, Horn T, Gilliam AC. A variant of nephro-genic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of dysregulated matrix remodeling? J Cutan Pathol 2004;31(3):262–5.

    Article  PubMed  Google Scholar 

  • Jolles S, Hughes J. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyo-derma gangrenosum, psoriasis, and pretibial myxedema. Int Immunopharmacol. 2006;6(4):579–91.

    Article  PubMed  CAS  Google Scholar 

  • Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E. Gadolinium-induced nephro-genic systemic fibrosis in a patient with an acute and transient kidney injury. Br J Dermatol. 2008;158(3):607–10.

    Article  PubMed  CAS  Google Scholar 

  • Kane GC, Stanson AW, Kalnicka D, Rosenthal DW, Lee CU, Textor SC, Garovic VD. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant. 2008;23(4):1233–40.

    Article  PubMed  CAS  Google Scholar 

  • Kukova G, Bruch-Gerharz D, Gensch K, Ruzicka T, Reifenberger J. Skleromyxödem. Hautarzt. 2006;57(4):326–7.

    Article  PubMed  CAS  Google Scholar 

  • Kulczycki A, Nelson M, Eisen A, Heffernan M. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol. 2003;149(6):1276–81.

    Article  PubMed  CAS  Google Scholar 

  • Larsen PR, Davies TF, Schlumberger MJ, Hay ID: Thyroid physiology and diagnostci evalulation of patients with thyroid disorders, pp 33–37. In: Williams Textbook of Endocrinology, 10th Edition, Eds: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, Saunders, PA, 2003.

    Google Scholar 

  • Lin YC, Wang HC, Shen JL. Scleromyxedema: An experience using treatment witth systemic cor-ticosteroid an review of the published work. J Dermatol. 2006;33(3):207–10.

    Article  PubMed  Google Scholar 

  • Moreno-Romero JA, Segura S, Mascaro JM, Cowper SE, Julia M, Poch E, Botey A, Herrero C. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor. Br J Dermatol. 2007; 157:783–787.

    Article  PubMed  CAS  Google Scholar 

  • O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves M W. Thyroid autoim-munity in chronic urticaria. Br J Dermatol. 2005;153(2):331–5.

    Article  PubMed  Google Scholar 

  • Pomann JJ, Rudner EJ. Scleromyxedema revisited. Int J Dermatol. 2003;42(1):31–5.

    Article  PubMed  Google Scholar 

  • Pryor JG, Poggioli G, Galaria N, Gust A, Robison J, Samie F, Hanjani NM, Scott GA. Neph-rogenic systemic fibrosis: a clinicopathologic study of six cases. J Am Acad Dermatol. 2007;57(1):105–11.

    Article  PubMed  Google Scholar 

  • Sansbury JC, Cocuroccia B, Jorizzo JL, Gubinelli E, Gisondi P, Girolomoni G. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol. 2004;51(1):126–31.

    Article  PubMed  Google Scholar 

  • Sulit DJ, Harford R, O'Neill JT. Discrete papular form of lichen myxedematosus: a case report and review of the literature. Cutis. 2005;75(2):105–12.

    PubMed  Google Scholar 

  • Thakral C, Abraham JL. Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin. J Electron Microsc (Tokyo). 2007;56(5):181–7.

    Article  Google Scholar 

  • Tokuda Y, Kawachi S, Murata H, Saida T. Chronic obesity lymphoedematous mucinosis: three cases of pretibial mucinosis in obese patients with pitting oedema. Br J Dermatol. 2006;154(1):157–61.

    Article  PubMed  CAS  Google Scholar 

  • Truhan A P, Roenigk HH Jr. The cutaneous mucinoses. J Am Acad Dermatol. 1986;14(1):1–18.

    Article  PubMed  CAS  Google Scholar 

  • Zakon SJ, Johnson JH, Grinvalsky H. Lichen myxedematosus (papular mucinosis Dalton and Sidell); report of an additional case. AMA Arch Derm. 1959;79(5):519–23.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2009). Thyroid Hormones. In: Cutaneous Manifestations of Endocrine Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-88367-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-88367-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-88366-1

  • Online ISBN: 978-3-540-88367-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation